InvoCare Management
Management criteria checks 2/4
InvoCare's CEO is Olivier Chretien, appointed in Jan 2021, has a tenure of 2.83 years. total yearly compensation is A$2.50M, comprised of 44.6% salary and 55.4% bonuses, including company stock and options. directly owns 0.043% of the company’s shares, worth €471.67K. The average tenure of the management team and the board of directors is 4.7 years and 5.1 years respectively.
Key information
Olivier Chretien
Chief executive officer
AU$2.5m
Total compensation
| CEO salary percentage | 44.6% |
| CEO tenure | 2.8yrs |
| CEO ownership | 0.04% |
| Management average tenure | 4.7yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2023 | n/a | n/a | -AU$38m |
| Mar 31 2023 | n/a | n/a | -AU$20m |
| Dec 31 2022 | AU$2m | AU$1m | -AU$2m |
| Sep 30 2022 | n/a | n/a | AU$67m |
| Jun 30 2022 | n/a | n/a | AU$78m |
| Mar 31 2022 | n/a | n/a | AU$79m |
| Dec 31 2021 | AU$2m | AU$1m | AU$80m |
Compensation vs Market: Olivier's total compensation ($USD1.63M) is above average for companies of similar size in the German market ($USD1.19M).
Compensation vs Earnings: Olivier's compensation has increased whilst the company is unprofitable.
CEO
Olivier Chretien (56 yo)
2.8yrs
Tenure
AU$2,497,884
Compensation
Mr. Olivier J. Chretien, MBA MEng GAICD, serves as Chief Executive Officer and Managing Director at InvoCare Limited since January 1, 2021 and serves as its Director since January 4, 2021. He was Group Chi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 2.8yrs | AU$2.50m | 0.043% € 471.7k | |
| Chief Financial Officer | 3.3yrs | AU$1.67m | 0.019% € 205.0k | |
| Company Secretary & Corporate Counsel | 4.7yrs | no data | no data | |
| Group Executive of Human Resources | 6.1yrs | no data | no data | |
| Advisor | 4.7yrs | no data | no data | |
| Chairman of New Zealand | 12.4yrs | no data | no data | |
| Chief Customer Officer | 3.2yrs | no data | no data | |
| Executive General Manager of Health | no data | no data | no data |
4.7yrs
Average Tenure
Experienced Management: IF3's management team is considered experienced (4.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD, CEO & Director | 2.8yrs | AU$2.50m | 0.043% € 471.7k | |
| Chairman of New Zealand | 12.4yrs | no data | no data | |
| Independent Non-Executive Director | 11.8yrs | AU$142.84k | 0.084% € 923.0k | |
| Independent Non-Executive Chairman | 6.1yrs | AU$285.69k | 0.014% € 148.8k | |
| Independent Non-Executive Director | 2.5yrs | AU$154.40k | 0.011% € 118.3k | |
| Independent Non-Executive Director | 5.2yrs | AU$154.40k | 0.0056% € 61.3k | |
| Independent Non-Executive Director | 5.1yrs | AU$142.84k | no data | |
| Independent Non-Executive Director | 2yrs | AU$142.84k | 0.0044% € 48.5k |
5.1yrs
Average Tenure
65yo
Average Age
Experienced Board: IF3's board of directors are considered experienced (5.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/11/03 00:40 |
| End of Day Share Price | 2023/09/29 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
InvoCare Limited is covered by 19 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Hester | ANZ Equities Pty Limited |
| Russell Wright | APP Securities Pty Ltd. |
| Russell Wright | Barclay Pearce Capital Pty Limited |